Past history of hypersensitivity to aripiprazole
Primary diagnosis of MDD with psychotic feature, bipolar disorder, schizophrenia, schizoaffective disorder, other psychotic disorder or anxiety disorder, a history of alcohol/ drug abuse within the past 12 months, or a diagnosis of dementia
Clinically significant current Axis II (DSM-IV-TR) diagnosis
A significant risk of suicide corroborated by a score of =5 on item 10(suicidal thoughts) on the MADRS scale or by clinical judgment of the investigator
Pregnancy or in breast-feeding
Presence of a serious medical illness including cardiac, hepatic, renal, respiratory, endocrinologic, neurologic, or hematologic disease or physical disorder judged to significantly affect central nervous system function
Patients taking antipsychotics, mood stabilizer or any psychotropic medications besides antidepressants, except benzodiazepines or beta blockers or hypnotics
Patients with past treatment failures of aripiprazole

NCT01696617_exc_T1
Condition
hypersensitivity
NCT01696617_exc_T2
Drug
aripiprazole
NCT01696617_exc_T3
Condition
MDD
NCT01696617_exc_T4
Condition
psychotic feature
NCT01696617_exc_T5
Condition
bipolar disorder
NCT01696617_exc_T6
Condition
schizophrenia
NCT01696617_exc_T7
Condition
schizoaffective disorder
NCT01696617_exc_T8
Condition
psychotic disorder
NCT01696617_exc_T9
Qualifier
other
NCT01696617_exc_T10
Condition
anxiety disorder,
NCT01696617_exc_T11
Condition
drug abuse
NCT01696617_exc_T12
Condition
lcohol/ buse
NCT01696617_exc_T13
Temporal
within the past 12 months
NCT01696617_exc_T14
Condition
dementia
NCT01696617_exc_T15
Scope
alcohol/ drug abuse
NCT01696617_exc_T16
Scope
psychotic feature, bipolar disorder, schizophrenia, schizoaffective disorder, other psychotic disorder or anxiety disorder
NCT01696617_exc_T17
Qualifier
Axis II
NCT01696617_exc_T18
Condition
diagnosis
NCT01696617_exc_T19
Qualifier
DSM-IV-TR
NCT01696617_exc_T20
Observation
risk of suicide
NCT01696617_exc_T21
Qualifier
significant
NCT01696617_exc_T22
Measurement
MADRS scale
NCT01696617_exc_T23
Value
score of =5 on item 10
NCT01696617_exc_T26
Qualifier
serious
NCT01696617_exc_T28
Condition
medical illness
NCT01696617_exc_T27
Condition
cardiac
NCT01696617_exc_T29
Condition
hepatic
NCT01696617_exc_T30
Condition
renal
NCT01696617_exc_T31
Condition
respiratory
NCT01696617_exc_T32
Condition
endocrinologic
NCT01696617_exc_T33
Condition
neurologic
NCT01696617_exc_T34
Condition
hematologic disease
NCT01696617_exc_T35
Condition
physical disorder
NCT01696617_exc_T37
Drug
antipsychotics
NCT01696617_exc_T38
Drug
mood stabilizer
NCT01696617_exc_T39
Drug
psychotropic medications
NCT01696617_exc_T40
Negation
besides
NCT01696617_exc_T41
Drug
antidepressants
NCT01696617_exc_T42
Negation
except
NCT01696617_exc_T43
Drug
benzodiazepines
NCT01696617_exc_T44
Drug
beta blockers
NCT01696617_exc_T45
Drug
hypnotics
NCT01696617_exc_T46
Scope
benzodiazepines or beta blockers or hypnotics
NCT01696617_exc_T47
Scope
psychotropic medications besides antidepressants
NCT01696617_exc_T48
Drug
aripiprazole
NCT01696617_exc_T49
Observation
treatment failures